Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Type”

178 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 178 results

Large-scale testing (Phase 3)Study completedNCT03226522
What this trial is testing

Addressing Dementia Via Agitation-Centered Evaluation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 366
Not applicableWithdrawnNCT04100889
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+20 more
ProgenaBiome
Not applicableNot Yet RecruitingNCT06474013
What this trial is testing

A Clinical Trial to Evaluate the Initial Safety and Efficacy of Repetitive BBB (Blood Brain Barrier) Disruption Using High Intensity Focused Ultrasound 'ExAblate 4000 Type 2.1' in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Korea University Anam Hospital 15
Large-scale testing (Phase 3)Study completedNCT00322153
What this trial is testing

The Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Dementia of the Alzheimer's Type
Forest Laboratories 677
Testing effectiveness (Phase 2)Study completedNCT02185053
What this trial is testing

A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia

Who this might be right for
Alzheimer's Disease
Chase Pharmaceuticals Corporation, an affiliate of Allergan plc 41
Large-scale testing (Phase 3)Study completedNCT00105547
What this trial is testing

Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

Who this might be right for
Alzheimer DiseaseDementia
Myrexis Inc. 1,600
Testing effectiveness (Phase 2)Study completedNCT01148498
What this trial is testing

A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 55
Testing effectiveness (Phase 2)Study completedNCT00470418
What this trial is testing

Development of NIC5-15 in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
VA Office of Research and Development 15
Testing effectiveness (Phase 2)Study completedNCT06292351
What this trial is testing

DMB-I in the Treatment of Alzheimer Type Dementia

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
Bigespas LTD 133
Large-scale testing (Phase 3)Ended earlyNCT04408755
What this trial is testing

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 184
Not applicableStudy completedNCT05350514
What this trial is testing

Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetes, Youth Onset
University of Colorado, Denver 14
Testing effectiveness (Phase 2)Study completedNCT04491006
What this trial is testing

ATH-1017 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
Athira Pharma 77
Early research (Phase 1)Study completedNCT01297218
What this trial is testing

The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease

Who this might be right for
Dementia of the Alzheimer's Type
Medipost Co Ltd. 9
Large-scale testing (Phase 3)Study completedNCT00259454
What this trial is testing

Project COPE:Managing Dementia at Home

Who this might be right for
Dementia, Alzheimer Type
Thomas Jefferson University 278
Large-scale testing (Phase 3)Study completedNCT00348140
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 1,468
Post-approval studies (Phase 4)Study completedNCT01478633
What this trial is testing

Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil

Who this might be right for
Alzheimer's Disease
Janssen Pharmaceutical K.K. 102
Not applicableLooking for participantsNCT05893524
What this trial is testing

Uppsala-Dalarna Dementia and Gait Project

Who this might be right for
DementiaDementia, MixedDementia Senile+3 more
Dalarna University 550
Testing effectiveness (Phase 2)Looking for participantsNCT06597942
What this trial is testing

Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)

Who this might be right for
Alzheimer&Amp;Amp;#39;s DiseaseAlzheimer DiseaseDementia Alzheimer Type+4 more
University of California, Los Angeles 54
Early research (Phase 1)Study completedNCT02840279
What this trial is testing

A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects

Who this might be right for
Alzheimer's Disease
Tetra Discovery Partners 77
Testing effectiveness (Phase 2)Study completedNCT02434666
What this trial is testing

Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07

Who this might be right for
Dementia of the Alzheimer's Type
Chase Pharmaceuticals Corporation, an affiliate of Allergan plc 21
Load More Results